How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Computerized Gel Imaging System Market
- By Product Type: Gel Documentation Systems, Gel Imaging Systems, Gel Analysis Software, Fluorescence Gel Imaging Systems, Chemiluminescence Imaging Systems
- By Application: DNA/RNA Analysis, Protein Analysis, Cell Imaging, Western Blot Analysis, Gel Electrophoresis Documentation
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Diagnostics Laboratories, Contract Research Organizations (CROs), Food and Beverage Industry
- By Detection Technology: UV Transillumination, Visible Light Imaging, Fluorescence Detection, Chemiluminescence Detection, CCD Camera Imaging
- By Software Features: Quantitative Analysis, Image Capture and Storage, Multi-channel Imaging, Automated Gel Analysis, Data Management and Reporting
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Gel Documentation Systems leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Computerized Gel Imaging System Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Application 5
End User 5
Detection Technology 5
Software Features 5
Companies profiled
Bio-Rad Laboratories Inc.
GE Healthcare Life Sciences (Cytiva)
Azure Biosystems
LI-COR Biosciences
Syngene International Ltd.
Vilber Lourmat
Analytik Jena AG
UVP (Analytik Jena brand)
Alpha Innotech (a division of ProteinSimple)
Peqlab Biotechnologie GmbH
Cleaver Scientific Ltd.
Herolab GmbH
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bio-Rad Laboratories Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GE Healthcare Life Sciences (Cytiva)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Azure Biosystems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →LI-COR Biosciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Syngene International Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Vilber Lourmat
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Analytik Jena AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →UVP (Analytik Jena brand)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Alpha Innotech (a division of ProteinSimple)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Peqlab Biotechnologie GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cleaver Scientific Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Herolab GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →DNR Bio-Imaging Systems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Clinx Science Instruments Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Major Science
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$3,328M by 2033 · 5.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Gel Documentation Systems29.7
- Gel Imaging Systems15.4
- Gel Analysis Software20.5
- Fluorescence Gel Imaging Systems17.9
- Chemiluminescence Imaging Systems16.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$727.0M → $1,136M · 5.7%
Europe$506.7M → $710.2M · 4.3%
Asia Pacific$462.6M → $719.2M · 5.7%
Latin America$286.4M → $386.5M · 3.8%
Middle East and Africa$220.3M → $324.9M · 5.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.242026
5.252027
5.262028
5.292029
5.292030
5.312031
5.322032
5.322033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bio-Rad Laboratories Inc.27.9
- GE Healthcare Life Sciences (Cytiva)11.2
- Azure Biosystems10.4
- LI-COR Biosciences7.2
- Syngene International Ltd.5.9
- Vilber Lourmat9.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type28.3%
Application23.2%
End User20.4%
Detection Technology16.6%
Software Features11.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.7
- Europe21.7
- Asia Pacific21.9
- Latin America11.8
- Middle East and Africa9.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. | 93 | 97 | 86 | 75 | 85 | 91 | 88 |
| GE Healthcare Life Sciences (Cytiva) | 68 | 78 | 93 | 71 | 71 | 77 | 76 |
| Azure Biosystems | 81 | 66 | 71 | 80 | 82 | 68 | 75 |
| LI-COR Biosciences | 62 | 60 | 74 | 58 | 64 | 77 | 66 |
| Syngene International Ltd. | 65 | 56 | 59 | 66 | 77 | 69 | 65 |
| Vilber Lourmat | 52 | 58 | 67 | 64 | 50 | 56 | 58 |
| Analytik Jena AG | 65 | 43 | 62 | 51 | 65 | 62 | 58 |
| UVP (Analytik Jena brand) | 42 | 46 | 53 | 37 | 55 | 40 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bio-Rad Laboratories Inc.
- GE Healthcare Life Sciences (Cytiva)
- Azure Biosystems
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bio-Rad Laboratories Inc. | ✓ | ✓ | ✓ | ◐ | ◐ | ✓ |
| GE Healthcare Life Sciences (Cytiva) | − | ◐ | ✓ | − | ✓ | ✓ |
| Azure Biosystems | ✓ | ◐ | ◐ | ✓ | ◐ | − |
| LI-COR Biosciences | ◐ | − | ◐ | − | ◐ | ◐ |
| Syngene International Ltd. | ◐ | ◐ | − | ◐ | ◐ | ◐ |
| Vilber Lourmat | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| Analytik Jena AG | ◐ | − | ◐ | − | ◐ | ◐ |
| UVP (Analytik Jena brand) | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bio-Rad Laboratories Inc.88
2GE Healthcare Life Sciences (Cytiva)76
3Azure Biosystems75
4LI-COR Biosciences66
5Syngene International Ltd.65
6Vilber Lourmat58
7Analytik Jena AG58
8UVP (Analytik Jena brand)46
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Bio-Rad Laboratories Inc.
Challenger2
Strong scale, closing on the leaders.
GE Healthcare Life Sciences (Cytiva)Azure Biosystems
Contender4
Focused players with pockets of strength.
LI-COR BiosciencesSyngene International Ltd.Vilber LourmatAnalytik Jena AG
Niche1
Specialists in a single segment or region.
UVP (Analytik Jena brand)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Computerized Gel Imaging System Market — a $657M beachhead inside a $11.0B market.
Beachhead (SOM)$657Mobtainable near-term
Serviceable (SAM)$4.18Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Gel Documentation Systems
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Gel Imaging Systems
Strong fit — clear ROI and a fast path to value.
End user66 fit
Gel Analysis Software
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Computerized Gel Imaging System Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation11%
Closed-won5%
$19.0KCAC
$97KLTV
5.1:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Computerized Gel Imaging System Market is a resilient opportunity — $1.66B by 2033, compounding at 5.7%.
TAM · 2025$1.06Btoday
TAM · 2033$1.66Bforecast
CAGR5.7%2027–2033
Cumulative$12.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.66BTotal addressable market
SAM$585MServiceable available market
SOM$103MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.7% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.66BLarge & growingTAM by 2033 at 5.7% CAGR
$585MServiceable nowreachable with today’s model
$103MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.30BBear3.7% CAGR
$1.66BBase5.7% CAGR
$2.13BBull7.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Computerized Gel Imaging System Market — a $1.70B market by 2033. Plan: grow share from 8.4% to 17.6%.
Market size · 2033$1.70Btotal addressable
Market CAGR6.8%2027–2033
Target share17.6%from 8.4% today
Revenue ambition$299Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 17.6% | Ahead |
| Revenue | $142M | $299M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.6% | 40.2% | Ahead |
| Customer retention | 85.4% | 93.7% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $34M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Computerized Gel Imaging System Market conversation — a $2.25B market you can size, segment and defend in minutes.
Market size · 2033$2.25Btotal opportunity
Growth3.5%CAGR to 2033
Addressable buyers904+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 4 mopayback period
$55K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Bio-Rad Laboratories Inc.GE Healthcare Life Sciences (Cytiva)Azure BiosystemsLI-COR BiosciencesSyngene International Ltd.Vilber LourmatAnalytik Jena AGUVP (Analytik Jena brand)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Computerized Gel Imaging System Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Computerized Gel Imaging System Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Computerized High Speed Gravure Printing Machine Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportComputerized Lace Crochet Machine Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportComputerized Navigation System Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportComputers-On-Modules (Coms) Market
Market size, share, segmentation and regional forecast.
$413M market · 2025 base year
View reportComputing Machinery and Parts and Accessories Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportCon Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportConcave Induction Cooker Market
Market size, share, segmentation and regional forecast.
$747M market · 2025 base year
View reportConcealed Sprinkler Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportConcealed Toilet Cistern Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportConcealers Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportConcealment Trolleys Market
Market size, share, segmentation and regional forecast.
$495M market · 2025 base year
View reportConcentrate Organic Soy Protein Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.